谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer (LA/mBC): Randomized phase 2 results

J. Crown,M-P Sablin, J. Cortes,J. Bergh,S-A Im,Y-S Lu,N. Martinez,P. Neven,K. S. Lee,S. Morales,J. A. Perez-Fidalgo,D. Adamson,A. Goncalves,A. Prat,G. Jerusalem, L. Schlieker, R-M Espadero,T. Bogenrieder,D. Chin-Lun Huang,P. Schmid

CANCER RESEARCH（2019）

引用 5|浏览26
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要